Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 133

    1.

    Science review: recombinant human erythropoietin in critical illness: a role beyond anemia?

    Coleman T, Brines M.

    Crit Care. 2004 Oct;8(5):337-41. Epub 2004 Jun 16. Review.PMID: 15469595 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Erythropoietin in the critically ill - is it more than just blood?

    Corwin HL.

    Crit Care. 2004 Oct;8(5):325-6. Epub 2004 Sep 6.PMID: 15469592 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Recombinant human erythropoietin protects the myocardium from ischemia-reperfusion injury and promotes beneficial remodeling.

    Calvillo L, Latini R, Kajstura J, Leri A, Anversa P, Ghezzi P, Salio M, Cerami A, Brines M.

    Proc Natl Acad Sci U S A. 2003 Apr 15;100(8):4802-6. Epub 2003 Mar 27.PMID: 12663857 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Erythropoietin-mediated tissue protection: reducing collateral damage from the primary injury response.

    Brines M, Cerami A.

    J Intern Med. 2008 Nov;264(5):405-32. Review.PMID: 19017170 [PubMed - indexed for MEDLINE]Related articles

    5.

    Erythropoietin selectively attenuates cytokine production and inflammation in cerebral ischemia by targeting neuronal apoptosis.

    Villa P, Bigini P, Mennini T, Agnello D, Laragione T, Cagnotto A, Viviani B, Marinovich M, Cerami A, Coleman TR, Brines M, Ghezzi P.

    J Exp Med. 2003 Sep 15;198(6):971-5.PMID: 12975460 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Effects of recombinant hematopoietins on blood-loss anemia in mice.

    Jones KB, Anderson DW, Longmore GD.

    Iowa Orthop J. 2005;25:129-34.PMID: 16089085 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Therapeutic potential of erythropoietin in cardiovascular disease: erythropoiesis and beyond.

    Westenbrink BD, Voors AA, Ruifrok WP, van Gilst WH, van Veldhuisen DJ.

    Curr Heart Fail Rep. 2007 Sep;4(3):127-33. Review.PMID: 17883987 [PubMed - indexed for MEDLINE]Related articles

    8.

    Erythropoietin and myocardial protection: what's new?

    Joyeux-Faure M, Godin-Ribuot D, Ribuot C.

    Fundam Clin Pharmacol. 2005 Aug;19(4):439-46. Review.PMID: 16011730 [PubMed - indexed for MEDLINE]Related articles

    9.

    A statistical pattern recognition approach for determining cellular viability and lineage phenotype in cultured cells and murine bone marrow.

    Quinn J, Fisher PW, Capocasale RJ, Achuthanandam R, Kam M, Bugelski PJ, Hrebien L.

    Cytometry A. 2007 Aug;71(8):612-24.PMID: 17542025 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Erythropoietin is a multifunctional tissue-protective cytokine.

    Erbayraktar S, Yilmaz O, Gökmen N, Brines M.

    Curr Hematol Rep. 2003 Nov;2(6):465-70. Review.PMID: 14561390 [PubMed - indexed for MEDLINE]Related articles

    11.

    Erythropoietin and treatment of non-anemic conditions--cardiovascular protection.

    Fliser D, Haller H.

    Semin Hematol. 2007 Jul;44(3):212-7. Review.PMID: 17631185 [PubMed - indexed for MEDLINE]Related articles

    12.

    The enigma of the metabolic fate of circulating erythropoietin (Epo) in view of the pharmacokinetics of the recombinant drugs rhEpo and NESP.

    Jelkmann W.

    Eur J Haematol. 2002 Nov-Dec;69(5-6):265-74. Review.PMID: 12460230 [PubMed - indexed for MEDLINE]Related articles

    13.

    Cytoprotective doses of erythropoietin or carbamylated erythropoietin have markedly different procoagulant and vasoactive activities.

    Coleman TR, Westenfelder C, Tögel FE, Yang Y, Hu Z, Swenson L, Leuvenink HG, Ploeg RJ, d'Uscio LV, Katusic ZS, Ghezzi P, Zanetti A, Kaushansky K, Fox NE, Cerami A, Brines M.

    Proc Natl Acad Sci U S A. 2006 Apr 11;103(15):5965-70. Epub 2006 Apr 3.PMID: 16585502 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Cellular protection by erythropoietin: new therapeutic implications?

    Joyeux-Faure M.

    J Pharmacol Exp Ther. 2007 Dec;323(3):759-62. Epub 2007 Aug 23. Review.PMID: 17717190 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    [Erythropoietin: a new perspective in cardiovascular therapy]

    Raddino R, Robba D, Caretta G, Bonadei I, Teli M, Zanini G, Madureri A, Vizzardi E, Dei Cas L.

    Monaldi Arch Chest Dis. 2008 Dec;70(4):206-13. Review. Italian. PMID: 19263796 [PubMed - indexed for MEDLINE]Related articles

    16.

    Recombinant human erythropoietin use in a critically ill Jehovah's witness after cardiac surgery.

    Price S, Pepper JR, Jaggar SI.

    Anesth Analg. 2005 Aug;101(2):325-7, table of contents.PMID: 16037136 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    EPO tecting the endothelium.

    Peterson TE, Katusic ZS.

    Br J Pharmacol. 2007 Apr;150(7):823-5. Epub 2007 Mar 12.PMID: 17351666 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    The effect of recombinant human erythropoietin on neurovasculature repair after focal ischemic stroke in neonatal rats.

    Keogh CL, Yu SP, Wei L.

    J Pharmacol Exp Ther. 2007 Aug;322(2):521-8. Epub 2007 May 9.PMID: 17494864 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Erythropoietin is neuroprotective, improves functional recovery, and reduces neuronal apoptosis and inflammation in a rodent model of experimental closed head injury.

    Yatsiv I, Grigoriadis N, Simeonidou C, Stahel PF, Schmidt OI, Alexandrovitch AG, Tsenter J, Shohami E.

    FASEB J. 2005 Oct;19(12):1701-3. Epub 2005 Aug 12.PMID: 16099948 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Delayed administration of darbepoetin or erythropoietin protects against ischemic acute renal injury and failure.

    Johnson DW, Pat B, Vesey DA, Guan Z, Endre Z, Gobe GC.

    Kidney Int. 2006 May;69(10):1806-13.PMID: 16598197 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data